[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.238.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 29, 1965

Depressive States: A Pharmacotherapeutic Study

Author Affiliations

Chicago

 

by Anthony Hordern, C. G. Burt, and N. F. Holt, 166 pp, 15 illus, $7.50, Springfield, Ill: Charles C Thomas, Publisher, 1965.

JAMA. 1965;194(9):1026. doi:10.1001/jama.1965.03090220082041

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

The thesis of this volume is that amitriptyline (Elavil) hydrochloride is the drug of choice in the treatment of depressive states. A total of 137 female patients were treated in a double-blind, wellstructured, comprehensive analysis —clinical and statistical—of symptoms and response. Analysis of the tables and of the statements made, however, does not provide conclusive proof of the superiority of this drug.

After the first week of treatment, imipramine hydrochloride (Tofranil) was superior in effectiveness to amitriptyline; after one month's therapy, amitriptyline was superior; after six months follow-up, both drugs reached the finish line at the same time.

In terms of results, amitriptyline showed 84% improvement, and imipramine a 79% improvement in the 137 case studies.

Admitting that electric-shock therapy is simple, safe, and effective, the authors state that the relapse rate of patients treated with electric shock is between 20% and 30%. In the authors' series, the relapse

First Page Preview View Large
First page PDF preview
First page PDF preview
×